PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition

Yasir H. Ibrahim, José Baselga, Patricia Cozar et al.|Cancer Discovery|2012

Cited by 622